Home/Pipeline/Therapeutics Division Programs

Therapeutics Division Programs

Cardiovascular, Diabetes, Neurological, Renal, Metabolic disorders

Pre-clinicalActive

Key Facts

Indication
Cardiovascular, Diabetes, Neurological, Renal, Metabolic disorders
Phase
Pre-clinical
Status
Active
Company

About Celprogen

Celprogen operates at the intersection of life science research tools and therapeutic development, leveraging stem cell technologies. The company has a diversified business model split into Therapeutics, Life Science (research products), and Device (assay systems) divisions. While it offers a vast catalog of research products like stem cells, media, and assay kits, its therapeutic pipeline appears to be in early, non-clinical stages. Its strategic positioning allows it to generate revenue from research tools while pursuing longer-term drug discovery goals.

View full company profile